University of California San Francisco
Displaying 11551 - 11580 of 16946
-
-
Archive: UCSF Scientists Play Key Role in Success of Yervoy, a New Cancer Drug
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
-
Archive: UCSF Botulism Research Translates Into Bioterrorism Treatment
<p>UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.</p>
-
Archive: Smithsonian: 30 Years Of HIV/AIDS
-
Archive: Read It and Weep, Crybabies
-
Archive: Legal Barriers to Wide HIV Testing Now Mostly Gone
-
Archive: All You Need is Love
-
Archive: New Faculty: Jeffrey D. Edwards
May 2011
-
Archive: Santa Cruz Skateboards Comes Up with New Deck for Kids with Cancer
-
Archive: UCSF Pushes the Frontiers of Knowledge of Cardiovascular Biology and Disease
<p>Blending state-of-the art technology and cutting-edge design, UCSF’s new cardiovascular research building at Mission Bay integrates basic and clinical research to address important questions in cardiovascular biology and disease. </p>
-
Archive: UCSF Scientists Honored by National Academy of Sciences
Alexander D. Johnson, PhD, and Shinya Yamanaka, MD, PhD, have been elected as members of the National Academy of Sciences (NAS) for their excellence in original scientific research.
-
Archive: Sugar as a Potential Health Risk is Getting a Closer Look
<p>Sugar is a poison, and conventional thinking about the role of hormones in metabolism is wrong, according to UCSF pediatrician Robert Lustig. His work is gaining attention in the mainstream media. </p>
-
Archive: Letter to the Editor: Help for Patients with ALS
-
Archive: Search Your Doctor: Study Finds Oversight Lacking in CA
-
Archive: A Drug Used for Maintenance Treatment of Bipolar Disorder Lacks Evidence, Scientists Contend
-
Archive: Hysterectomy 'Lowers Ovarian Cancer Risk'
-
Archive: Ray and Dagmar Dolby Regeneration Medicine Building
-
Archive: Lawrence H. Diller's New Book on Ritalin
-
Archive: Education Day Showcases Scholarly Work
<p><span class="Apple-style-span">Interprofessional education was a recurring theme at UCSF's Education Day when scholars from all four professional schools showcased their work and discussed how to change and adapt teaching in ways that transcend traditional boundaries.</span></p>
-
Archive: Massive Clean Up is No Cure for Hoarding
-
Archive: Figuring the Odds
-
Archive: Why PTSD is Larger than Mental Health
-
Archive: Doctor Focuses on the Minds of the Elderly
-
Archive: UCSF Scientists Praise Decision on Broader Federal Funding for Stem Cell Research
-
Archive: UCSF Doctors Try Out New Laparoscopic Equipment
-
Archive: The Real Winners in the Pharma Patent Cliff
-
Archive: US Appeals Court Opens Federal Funding for Stem Cell Research
The U.S. Federal Court of Appeals has overturned an August 2010 ban on federal funding of embryonic stem cell research, paving the way for broader exploration of how stem cells function and how they can be harnessed to treat a wide range of currently incurable diseases.
-
Archive: Stem Cell Judgment Reaction Round-Up
-
Archive: Kate Middleton's Health: Did The Wedding Take A Toll?
-
Archive: Gastroenterologist Marvin Sleisenger Honored With UCSF Award